X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (42) 42
dermatology (35) 35
index medicus (32) 32
tartrate gel 0.5-percent (31) 31
severe facial erythema (28) 28
female (23) 23
brimonidine (21) 21
rosacea (21) 21
moderate (20) 20
rosacea - drug therapy (20) 20
brimonidine tartrate (19) 19
efficacy (18) 18
male (18) 18
safety (18) 18
double-blind (17) 17
erythema (17) 17
middle aged (16) 16
adult (13) 13
papulopustular rosacea (13) 13
treatment outcome (11) 11
0.5-percent (10) 10
administration, cutaneous (10) 10
aged (10) 10
dermatologic agents - administration & dosage (10) 10
erythema - drug therapy (10) 10
ophthalmology (10) 10
dermatologic agents - therapeutic use (9) 9
glaucoma (9) 9
management (9) 9
pathophysiology (9) 9
quinoxalines - therapeutic use (9) 9
consensus recommendations (8) 8
skin (8) 8
topical brimonidine (8) 8
acne rosacea (7) 7
administration, topical (7) 7
double-blind method (7) 7
drug therapy (7) 7
erythema - etiology (7) 7
quinoxalines - administration & dosage (7) 7
0.2-percent (6) 6
american acne (6) 6
antihypertensive agents - therapeutic use (6) 6
antiinflammatory dose doxycycline (6) 6
brimonidine tartrate - administration & dosage (6) 6
gels (6) 6
ocular hypertension (6) 6
open-angle glaucoma (6) 6
rosacea - complications (6) 6
rosacea - therapy (6) 6
timolol 0.5-percent (6) 6
acid 15-percent gel (5) 5
adrenergic alpha-2 receptor agonists - administration & dosage (5) 5
brimonidine tartrate - adverse effects (5) 5
brimonidine tartrate - therapeutic use (5) 5
care and treatment (5) 5
internal medicine (5) 5
intraocular pressure - drug effects (5) 5
ivermectin - administration & dosage (5) 5
metronidazole 0.75-percent cream (5) 5
patient satisfaction (5) 5
quality-of-life (5) 5
quinoxalines - adverse effects (5) 5
rosacea - pathology (5) 5
surgery (5) 5
trial (5) 5
young adult (5) 5
adrenergic alpha-2 receptor agonists - therapeutic use (4) 4
adrenergic alpha-agonists - therapeutic use (4) 4
aged, 80 and over (4) 4
analysis (4) 4
classification (4) 4
clinical trials (4) 4
dosage and administration (4) 4
glaucoma - drug therapy (4) 4
inflammation (4) 4
ivermectin 1-percent cream (4) 4
medicine & public health (4) 4
oxymetazoline - therapeutic use (4) 4
quality of life (4) 4
research (4) 4
rosacea - diagnosis (4) 4
rosacea - physiopathology (4) 4
serine-protease activity (4) 4
severity of illness index (4) 4
vasoconstriction (4) 4
1-year (3) 3
antihypertensive agents - adverse effects (3) 3
demodex (3) 3
demodex-folliculorum (3) 3
dermatitis (3) 3
dermatologic agents - adverse effects (3) 3
dicarboxylic acids - therapeutic use (3) 3
dose-response (3) 3
doxycycline (3) 3
drug administration schedule (3) 3
erythematotelangiectatic rosacea (3) 3
expression (3) 3
face (3) 3
facial dermatoses - drug therapy (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Optometry and Vision Science, ISSN 1040-5488, 03/2018, Volume 95, Issue 3, pp. 264 - 271
SIGNIFICANCEThe α2-adrenergic receptor agonist brimonidine has been reported to induce conjunctival blanching in cataract, strabismus, laser refractive, and... 
OPEN-ANGLE GLAUCOMA | TIMOLOL 0.5-PERCENT | PROPHYLACTIC BRIMONIDINE | STRABISMUS SURGERY | DOUBLE-BLIND | OPHTHALMOLOGY | SOLUTION 0.2-PERCENT | ALPHA-ADRENOCEPTOR AGONISTS | TARTRATE GEL 0.5-PERCENT | SEVERE FACIAL ERYTHEMA | BLEEDING COMPLICATIONS | Original Investigations
Journal Article
The Cochrane database of systematic reviews, ISSN 1469-493X, 2015, Volume 4, Issue 5, p. CD003262
Journal Article
by Hsia, E and Tian, MT and Gil, D
EXPERIMENTAL DERMATOLOGY, ISSN 0906-6705, 07/2018, Volume 27, Issue 7, pp. 763 - 768
When applied topically, oxymetazoline and brimonidine reduce the persistent facial erythema of rosacea; this effect is mediated by cutaneous vasoconstriction... 
MODERATE | animal models | MANAGEMENT | EFFICACY | rosacea | mechanism of action | TARTRATE GEL 0.5-PERCENT | DERMATOLOGY | RESPONSES | Alpha-adrenergic agonists | erythema | THERAPY | LIGAND | VASOCONSTRICTION | SEVERE FACIAL ERYTHEMA | Erythema | Skin
Journal Article
Journal of the European Academy of Dermatology and Venereology, ISSN 0926-9959, 06/2016, Volume 30, Issue 6, pp. 974 - 979
Journal Article
American Journal of Clinical Dermatology, ISSN 1175-0561, 12/2015, Volume 16, Issue 6, pp. 457 - 461
Rosacea is a common chronic inflammatory disorder that affects approximately 16 million Americans. The multifactorial pathophysiology of rosacea is not fully... 
IVERMECTIN 1-PERCENT CREAM | MANAGEMENT | LONG-TERM SAFETY | DOUBLE-BLIND | DOXYCYCLINE | TOPICAL BRIMONIDINE | TARTRATE GEL 0.5-PERCENT | TREATING INFLAMMATORY LESIONS | SEVERE FACIAL ERYTHEMA | PATHOPHYSIOLOGY | DERMATOLOGY
Journal Article
Clinics in Dermatology, ISSN 0738-081X, 2016, Volume 35, Issue 2, pp. 207 - 212
Journal Article